• Home
  • About
    • Overview
    • Sharing Data
    • ORCID
  • Help
  • History (4)
    • Cancer risks for MLH1 and MSH2 mutation carriers.
    • Germinoma
    • Psychology, Clinical
    • Selective induction of matrix metalloproteinases and tissue inhibitor of metalloproteinases in atrial and ventricular myocardium in patients with atrial fibrillation.
    • See All 4 Pages
  • search
    • Find People
    • Find Everything
Login to edit your profile (add a photo, awards, links to other websites, etc.)
  • Edit My Profile
  • My Person List (0)

Cancer risks for MLH1 and MSH2 mutation carriers.

Cancer risks for MLH1 and MSH2 mutation carriers. Hum Mutat. 2013 Mar; 34(3):490-7.

View in: PubMed

subject areas
  • Adaptor Proteins, Signal Transducing
  • Adult
  • Age Factors
  • Aged
  • Aged, 80 and over
  • Carrier Proteins
  • Colorectal Neoplasms
  • Colorectal Neoplasms, Hereditary Nonpolyposis
  • Endometrial Neoplasms
  • Female
  • Germ-Line Mutation
  • Heterozygote
  • Humans
  • Male
  • Middle Aged
  • MutL Protein Homolog 1
  • MutS Homolog 2 Protein
  • Nuclear Proteins
  • Penetrance
  • Risk Factors
  • Surveys and Questionnaires

authors with profiles
  • Robert W. Haile